...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Presentation is up
2
Jan 09, 2018 10:11AM
2
Jan 09, 2018 11:43AM

Disappointed to not see updated info on the progression of the combination cohort. We are now 5/6 weeks past the time that the info on chart 18 shows versus the AGM presentation. I'm really curious to see how those rock stars in the second cohort are doing. When asked during the AGM DM said the info was current to 2 weeks prior to the meeting(about 28 Nov). If these guys are still rocking it Zenith should be crowing from the tallest tree.

tada

2
Jan 09, 2018 02:28PM
Share
New Message
Please login to post a reply